Eric Sievers's Insider Trades & SAST Disclosures
Eric Sievers's most recent trade in BioAtla Inc was a trade of 175,000 Common Stock done . Disclosure was reported to the exchange on March 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Eric Sievers.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2025 | 175,000 | 370,032 | - | 0 | Common Stock | |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.46 per share. | 15 Feb 2025 | 12,530 | 195,032 | - | 0.5 | 5,764 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.77 per share. | 31 Aug 2024 | 572 | 207,562 | - | 1.8 | 1,012 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.81 per share. | 31 Jul 2024 | 572 | 208,134 | - | 1.8 | 1,035 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.37 per share. | 30 Jun 2024 | 572 | 208,706 | - | 1.4 | 784 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.51 per share. | 31 May 2024 | 572 | 209,278 | - | 1.5 | 864 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.26 per share. | 30 Apr 2024 | 572 | 209,850 | - | 2.3 | 1,293 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.44 per share. | 31 Mar 2024 | 572 | 210,422 | - | 3.4 | 1,968 | Common Stock |
| BioAtla Inc | Sievers Eric | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.70 per share. | 29 Feb 2024 | 572 | 210,994 | - | 2.7 | 1,544 | Common Stock |
| BioAtla Inc | Sievers Eric | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 122,000 | 211,566 | - | 0 | Common Stock | |
| BioAtla Inc | Sievers Eric | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.92 per share. | 31 Jan 2024 | 657 | 89,566 | - | 1.9 | 1,261 | Common Stock |
| BioAtla Inc | Sievers Eric | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.46 per share. | 31 Dec 2023 | 555 | 90,223 | - | 2.5 | 1,365 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.99 per share. | 31 Jul 2023 | 554 | 92,996 | - | 3.0 | 1,656 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.00 per share. | 30 Jun 2023 | 555 | 90,527 | - | 3 | 1,665 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.15 per share. | 31 May 2023 | 554 | 91,082 | - | 3.1 | 1,745 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.37 per share. | 30 Apr 2023 | 555 | 91,636 | - | 3.4 | 1,870 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.68 per share. | 31 Mar 2023 | 555 | 92,191 | - | 2.7 | 1,487 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2023 | 240,000 | 240,000 | - | - | Employee Stock Option (right to buy) | |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.98 per share. | 09 Feb 2023 | 554 | 92,746 | - | 3.0 | 1,651 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.79 per share. | 31 Jan 2023 | 654 | 93,300 | - | 3.8 | 2,479 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.25 per share. | 31 Dec 2022 | 554 | 93,954 | - | 8.3 | 4,571 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.01 per share. | 30 Nov 2022 | 555 | 94,508 | - | 11.0 | 6,111 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.89 per share. | 31 Oct 2022 | 554 | 85,063 | - | 6.9 | 3,817 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.70 per share. | 30 Sep 2022 | 555 | 85,617 | - | 7.7 | 4,274 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 8.71 per share. | 31 Aug 2022 | 555 | 86,172 | - | 8.7 | 4,834 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.40 per share. | 31 Jul 2022 | 554 | 86,727 | - | 3.4 | 1,884 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.85 per share. | 30 Jun 2022 | 555 | 87,281 | - | 2.9 | 1,582 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.41 per share. | 31 May 2022 | 554 | 87,836 | - | 2.4 | 1,335 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.48 per share. | 30 Apr 2022 | 555 | 88,390 | - | 3.5 | 1,931 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 5.00 per share. | 31 Mar 2022 | 554 | 88,945 | - | 5 | 2,770 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.48 per share. | 28 Feb 2022 | 555 | 89,499 | - | 6.5 | 3,596 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Feb 2022 | 122,000 | 122,000 | - | - | Employee Stock Option (right to buy) | |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.56 per share. | 31 Jan 2022 | 657 | 90,054 | - | 9.6 | 6,281 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.63 per share. | 31 Dec 2021 | 795 | 90,711 | - | 19.6 | 15,606 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.89 per share. | 29 Nov 2021 | 110 | 92,630 | - | 23.9 | 2,628 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.29 per share. | 22 Nov 2021 | 119 | 92,937 | - | 24.3 | 2,890 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 26.24 per share. | 22 Nov 2021 | 118 | 93,056 | - | 26.2 | 3,096 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 26.03 per share. | 22 Nov 2021 | 68 | 92,869 | - | 26.0 | 1,770 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 24.06 per share. | 22 Nov 2021 | 48 | 92,821 | - | 24.1 | 1,155 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.00 per share. | 22 Nov 2021 | 44 | 92,777 | - | 25 | 1,100 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 25.78 per share. | 22 Nov 2021 | 37 | 92,740 | - | 25.8 | 954 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 30.39 per share. | 01 Oct 2021 | 592 | 93,174 | - | 30.4 | 17,993 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 39.59 per share. | 26 Aug 2021 | 6,883 | 93,766 | - | 39.6 | 272,496 | Common Stock |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Other type of transaction at price $ 0.00 per share. | 14 Jun 2021 | 23,726 | 100,649 | - | 0 | Common Stock | |
| BioAtla Inc | Eric Sievers | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Dec 2020 | 77,471 | 77,471 | - | - | Employee Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges